2022 Archived Content
OVERVIEW | DOWNLOAD BROCHURE | SHORT COURSES | INTERACTIVE DISCUSSIONS | ATTENDEES
OPT Congress

The 8th Annual OPT Congress is Returning to Boston March 13-14, 2023

Sign Up For Updates!

OPT Congress 2022 Now On-Demand

Missed this year’s event? Register for On-Demand and at your convenience, access all the content from this year’s program from anywhere at any time for up to one year.

Register for On-Demand
View 2022 Highlights & Testimonials

Conference Programs

Add Dates to Outlook

Oligonucleotide Discovery and Delivery

Oligoncucleotide CMC and Regulatory Strategies

Short Courses
Event Highlights

Keynote Speakers Include:

Isabel Aznarez, PhD

Isabel Aznarez, PhD
Co-Founder, Vice President & Head, Biology, Stoke Therapeutics

Richard Geary, PhD

Richard Geary, PhD
Chief Development Officer and Executive Vice President, Antisense Drug Development, Ionis Pharmaceuticals, Inc.

Arthur M. Krieg

Arthur M. Krieg
Founder & CSO, Checkmate Pharmaceuticals

Arthur Levin, PhD

Arthur Levin, PhD
CSO, Avidity Biosciences

Michael Segel, PhD

Michael Segel, PhD
Postdoctoral Fellow, Laboratory of Dr. Feng Zhang, Broad Institute of MIT and Harvard

With Thanks to Our Executive Advisory Board

Dmitry Samarsky, PhD
CTO, Sirnaomics

Muthiah (Mano) Manoharan, PhD
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals

Arthur Levin, PhD
CSO, Avidity Biosciences

Lubo Nechev, PhD
Vice President Process and Analytical Sciences, Alnylam Pharmaceuticals

Ekkehard Leberer, PhD
Senior Life Sciences Consultant, ELBIOCON